Navigation Links
Martek Signs Sole-Source Supply Agreement with Fonterra
Date:12/10/2009

for infants and toddlers.

Martek Biosciences Corporation is a leader in the innovation and development of DHA and ARA and has developed patented technology for the production and use of these ingredients. DHA omega-3 products promote health and wellness through every stage of life and ARA omega-6 products support growth and development in infants and children. The company produces life'sDHA™, a sustainable vegetarian source of DHA omega-3, for use in foods, beverages, infant formula, perinatal products, and supplements, and life’sARA™, a sustainable vegetarian source of ARA omega-6, for use in infant formula and growing up milks. For more information on Martek Biosciences, visit http://www.martek.com/. For more information on products containing lifesDHA and life’sARA, visit www.lifesdha.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2008 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.

# # #

Read the full story at http://www.prweb.com/releases/dairy_fonterra/martek_biosciences/prweb3321614.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
2. Martek Announces Addition to Its Board of Directors
3. Martek to Present at Two Upcoming Investor Conferences
4. Martek Announces Settlement of Patent Dispute with Capsugel France
5. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
6. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
7. Martek to Announce Third Quarter 2009 Results
8. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
9. BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels
10. BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
11. EU Committee Approves New Food Applications for Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Martek Signs Sole-Source Supply Agreement with Fonterra
(Date:8/21/2014)... Chester, NJ (PRWEB) August 21, 2014 ... of personal selling optimization technology and services for ... publication of “Grading Pharma’s Use of New Commercial ... of Measurement & Analytics. , The article examines ... marketing yield that are being tested in the ...
(Date:8/21/2014)... August 21, 2014 SoundConnect ... been recognized as one of the nation’s Fastest ... magazine for the 2nd consecutive year. Inc. magazine ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ...
(Date:8/20/2014)... analysis of patented university inventions licensed to biotechnology ... to commercialization. To open these roadblocks, the researchers ... during the discovery stage could lead to faster ... frequently derived from discoveries made in university laboratories ... known during clinical trials, which have a high ...
(Date:8/20/2014)... Fla. , Aug. 20, 2014 ... will host a conference call to provide an ... 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. ... 9126599 Live web cast: www.neurotropebioscience.com , under "Investor ... hours after completion through September 2, 2014 at ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3Neurotrope To Host Conference Call 2
... Management and Patient,Safety Institute (RM&PSI) today announced its ... RM&PSI ( http://www.rmpsi.com ), a subsidiary of FinCor,Holdings ... in,clinical risk management and patient safety programs and ... The spring 2009 calendar also ...
... new white papers detailing sterility testing essentials are ... www.microtestlabs.com ). The white papers, one which ... which is specialized for pharmaceutical manufacturers, presents the ... and reviews different testing methodologies.For medical device manufacturers, ...
... NEOG ) has received approval from the ... its quick and easy BetaStar(R)US test,for dairy antibiotics in ... United States to use Neogen,s new test to comply ... for dairy antibiotics. , Neogen,s ...
Cached Biology Technology:The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates 2The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates 3Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2Neogen's BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS 2
(Date:8/21/2014)... study of American singles found that during sex ... orgasm rates. On average, men experience orgasm 85.1 ... making little difference. For women, however, orgasm occurrence ... 62.9 percent of the time during sex with ... with women,s sexual orientation, with lesbian women experiencing ...
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- LiveScan Service ... agreed to a partnership with Gabriel Health Institute, ... fastest growing Certified Nursing Assistant preparatory schools. ...  an exclusive member of Binary,s LiveScan service provider,s ... will improve its service capabilities by widening ...
(Date:8/21/2014)... window? It consists of radiations in the 3.3 to ... water in biological tissues. New theoretical findings show that ... water window. These could be the basis of an ... biological samples or to be used in high-precision spectroscopy. ... needed to efficiently generate the harmonic radiationswhich are multiples ...
Breaking Biology News(10 mins):Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3Water window imaging opportunity 2
... to each person or set of identical twins. That ... crime detection to international travel. But what happens when ... patterns of ridges? It,s not the premise ... known as adermatoglyphia. It,s also known as "Immigration Delay ...
... on the detrimental impact of some common medicines on elderly people ... a few of these medicines does not appear to cause further ... In a paper published today by the journal ... East Anglia (UEA) and colleagues from a number of other universities ...
... - The first fluorescence-guided surgery on an ovarian cancer patient ... agent created by a Purdue University researcher. The surgery ... phase of a clinical trial to evaluate a new technology ... ovarian cancer patients. The method illuminates cancer cells to help ...
Cached Biology News:Shake hands with the invisible man 2Reassurance for dementia sufferers on impact of common drugs 2Purdue technology used in first fluorescence-guided ovarian cancer surgery 2Purdue technology used in first fluorescence-guided ovarian cancer surgery 3Purdue technology used in first fluorescence-guided ovarian cancer surgery 4
Mouse monoclonal [0.N.509] to PCTAIRE2 ( Abpromise for all tested applications). entrezGeneID: 5128 SwissProtID: Q00537...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
... Zeba Desalt Spin Columns contain a proprietary ... offers exceptional desalting and protein-recovery characteristics compared ... as low as 25 g/ml of protein ... and > 95% retention of salts and ...
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507...
Biology Products: